Implementing a Contingency Management Program Addressing Methamphetamine Use For and With the People of Hawaii
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorQueen's Medical Center
About this trial
The goal of this clinical trial is to use contingency management (CM) as an intervention tool to address methamphetamine use.
The main objectives are to:
* Gather effectiveness data on a pilot a CM program for participants in Hawaii who use methamphetamine following hospitalization due to traumatic injury * To assess participant perspectives on engaging with a CM program based at a Level 1 Trauma Center. Researches will assess both patient-reported and biologically-confirmed medium-term program effectiveness and conduct qualitative interviews with participants post-program.
Participants will:
* Visit a follow-up clinic up to three times per week to complete urinalysis following discharge from the trauma unit * Complete Treatment Effectiveness Assessments at 6 and 12-weeks * Engage in a qualitative interview at the end of the CM program
Eligibility criteria
Qualifiers
Admitted trauma patients
Age greater than 18 years old
Urine drug screen positive for methamphetamines during the current hospitalization
Report at least weekly methamphetamine use
Disqualifiers
Active psychosis (reporting auditory or visual hallucinations)
Under ongoing cardiorespiratory monitoring
Evidence of moderate or severe traumatic brain injury
Patients who are known to be pregnant
Trial design
Treatments tested in this trial
- Contingency Managment
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Queen's Medical Center
Lead sponsor
National Institute of General Medical Sciences (NIGMS)
Collaborator
Source ClinicalTrials.gov